We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Life Science Analytics Market: Growth, Size, Share, and Trends

Report Code HIT 4869
Published in May, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Life Science Analytics Market by Type (Descriptive, Prescriptive, Predictive), by Service (Analytics), Application (Drug Discovery, Trials, RWE, Access, Sales & Marketing, Drug Safety), End User (Pharma, Medical Device) & Region - Global Forecast to 2030

Overview

The global life science analytics market, valued at US$35.69 billion in 2024, is forecasted to grow at a robust CAGR of 11.4%, reaching US$40.03 billion in 2025 and an impressive US$68.81 billion by 2030. The standardization of diverse datasets from sources such as clinical trials, electronic health records (EHRs), genomics, and real-world evidence is essential for the efficient exchange of information across various platforms and geographical regions. This standardization enhances multi-site clinical trials and cross-border research collaborations. Additionally, emerging technologies like artificial intelligence (AI), quantum computing, and cognitive computing play a vital role in transforming large volumes of raw data into actionable insights. These technologies help simplify reports and create interactive dashboards.

Furthermore, the increasing adoption of analytics in pre-clinical trials, drug discovery, and clinical trials, particularly for applications such as patient recruitment and site identification, helps to reduce the workload for researchers and investigators. These factors contribute significantly to the growing adoption of analytics across the life sciences industry.

Life Science Analytics Market– Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Life Science Analytics Market

Asia Pacific

Market growth in the Asia Pacific can be attributed to the presence of a large and growing patient population, an increasing need for innovative therapies, the emergence of big data in healthcare, and increasing spending on HCIT infrastructure.

Technological advancements in analytical solutions, the rising need for improved data standardization, and the growing adoption of analytical solutions in clinical trials are key factors driving the market growth.

The utilization of analytics in precision & personalized medicine and the growing adoption of cloud-based analytics solutions are expected to provide lucrative opportunities for market players.

The European life science analytics market is expected to be worth USD 21.78 billion by 2030, growing at a CAGR of 11.4% during the forecast period.

Issues associated with data integration and a shortage of skilled personnel are expected to challenge the growth of this market.

Global Life Science Analytics Market Dynamics

DRIVER: Technological advancements in analytical solutions

Technological advancements in analytics solutions help users simplify reports and create interactive dashboards that enable easy access and translation of huge volumes of raw data into actionable insights. In addition, with the constantly changing needs of pharmaceutical and biopharma companies and the growing focus on research and development, there is a surging demand for advanced analytics tools capable of handling these changing requirements. New technologies such as cognitive computing help address challenges such as harnessing large-volume data, integrating data from hundreds of sources, and understanding various data formats. Key companies in the market are investing in organic & inorganic strategies to leverage technologically sophisticated solutions in their life cycles & operations. For instance, in May 2024, TetraScience and Databricks announced a strategic partnership to advance Scientific AI in life sciences, aiming to accelerate the development of more effective and safer therapies by re-platforming data for large-scale AI-driven scientific insights and enhancing lab data management solutions across the entire value chain. Similarly, in May 2024, Trinity Life Sciences and WhizAI partnered to enable life science companies to quickly generate and share AI-driven insights by integrating WhizAl's conversational AI and visualization platform with Trinity's advanced data management solutions and advisory services. The collaboration aims to provide commercial teams with valuable insights for field sales, patient claims, market access, and patient services analytics, enhancing augmented analytics on Trinity's reporting platforms.

RESTRAINT: Data privacy concerns

The number of databases shared among research institutions, CROs, partners, and software companies has increased the risk of exposing sensitive patient information to undesired individuals. The US Health Information Technology for Economic and Clinical Health Act (HITECH) states that covered entities must protect individual health records and other identifiable health information by acquiring appropriate safeguards to protect privacy. The application of electronic tools for patient databases increases concerns regarding the safety and privacy of data. This creates a key challenge for pharmaceutical enterprises in complying with privacy policies while using analytics solutions.

For instance, as per an article published by IBM Security in 2022, the average cost of a mega breach increased to USD 241 million in 2022, compared to USD 230 million in 2021, demonstrating a growth of 4.8%. Moreover, according to the IBM-Ponemon Institute 2021 Cost of a Data Breach Report, the average total data breach cost in 2021 was USD 4.24 million, up from USD 3.86 million in 2020. The average cost of a data breach in the healthcare industry was USD 9.23 million in 2021, and for the life science industry, USD 5.04 million. These breaches were mainly due to the lack of internal control over patient information, top management support for streamlining data management, obsolete policies, procedures/nonadherence to existing ones, and insufficient personnel training.

 

OPPORTUNITY: Use of analytics in precision & personalized medicine

Precision medicine involves leveraging the genomic data of an individual to develop personalized medicine. Advanced analytics and predictive modeling applications can enable organizations to treat each patient in a customized way to produce the best possible outcomes. In recent years, analytics has increasingly been used to develop personalized medicine, primarily for cancer and diabetes. To develop analytics-based solutions for precision health, various organizations receive grants to develop personalized medicine-based big data solutions. For instance, in January 2023, Caris Life Sciences, a molecular science and technology company, raised a staggering USD 1.7 billion in funding. This investment is aimed at advancing their capabilities in precision medicine, particularly in molecular profiling and targeted therapies. Therefore, data analytics in precision medicine aids in patient diagnosis, biomarker discovery, prognosis, and disease subtyping. It can combine huge amounts of data from multi-omics, EHRs, and wearable & implantable devices in real-time for accurate analysis.

CHALLENGES: Shortage of skilled professionals

As the field increasingly relies on advanced technologies like artificial intelligence, machine learning, and big data, the requirement for skilled professionals who can navigate the complexities of data science, bioinformatics, and life science analytics is surging substantially. However, the limited availability of talent with the right blend of technical and domain expertise is slowing the adoption and development of innovative analytics solutions, affecting pharmaceutical & biotechnology companies and research institutions. Globally, the number of organizations equipped with sufficient in-house expertise capable of translating large volumes of data into valuable insights is limited. According to a report published by Randstad Sourceright's 2022 Talent Trends, 33% of C-suite & human capital leaders in the life sciences & pharma sector reported that talent scarcity is one of the major factors that challenge the growth of the life science sector.

Addressing this talent gap requires a multifaceted approach, including investment in training and education, industry-academic partnerships, and integration of user-friendly analytics tools.

Global Life Science Analytics Market Ecosystem Analysis

The ecosystem of the life science analytics market comprises investors, academic researchers/organizations, government and regulatory bodies, key players, startups, end users from the life science industry (pharmaceutical & biotechnology companies, medical device companies, research centers, and outsourced life science organizations). The ecosystem also includes enablers such as data source providers, ERP providers, business intelligence and analytical tool providers, cloud service providers, web interface and application developers, network connectivity providers, security and privacy solutions providers, hardware providers, and consultants.

Life Science Analytics Market
 

The descriptive analytics segment accounted for a substantial share of the life science analytics market, by type, in 2024.

The descriptive analytics segment held the largest share of the life science analytics market, by type, in 2024. The substantial share of this segment can be attributed to the surge in data from clinical trials, patient records, and research studies; growing emphasis on real-world data; and the growing demand for data-driven decision making. Additionally, descriptive analytics helps identify trends, measure performance, and facilitate collaboration that empowers researchers with limited data science experience meet regulatory & market demands for clear, actionable insights. These factors collectively drive the expansion of descriptive analytics, fostering innovation in the life science sector.

Commercial analytics is expected to register the highest growth in the life science analytics market, by application.

In 2024, the commercial analytics segment is expected to register the highest growth in the life science analytics market, by application, during the forecast period. The surging uptake of advanced analytics solutions by life science companies to align sales and marketing campaigns and the growing importance of post-marketing surveillance are the factors that primarily drive market growth. The applications offered by analytics, such as Salesforce designing and optimization, marketing ecosystem ROI analysis, analyzing digital marketing effectiveness, and creating decision dashboards for the life science value chain, further help in propelling the growth. Moreover, advancements in technology, such as artificial intelligence (AI) and machine learning, enable more efficient data processing and predictive modeling, contributing to the rapid expansion of commercial analytics capabilities. For instance, in November 2023, Axtria (US) launched Axtria DataMAX Emerging Pharma, an AI-enabled SaaS solution designed to help small and emerging biotech and pharmaceutical companies make data-driven decisions, streamline commercialization, and scale efficiently.

North America dominated the life science analytics market in 2024.

The life science analytics market is studied for five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The North American region dominated the life science analytics market owing to factors such as the region's high per-capita healthcare expenditure, ongoing developments in technologies, particularly in big data, artificial intelligence (AI), and cloud computing, the rising demand for personalized medicine driven by genomic data and patient-centric approaches, and the growing importance of analytics in R&D, sales, marketing, and supply chain optimization. The growing focus on quality control, regulatory compliance, developed healthcare & life sciences infrastructure, and the surging demand for digitalized technologies across North America further propels the growth. Moreover, the competitive landscape in North America encourages innovation among market players, driving continuous growth in technology and service offerings by various market vendors.

LARGEST MARKET SHARE IN 2023
US FASTEST-GROWING MARKET IN THE REGION
Life Science Analytics Market

Recent Developments of Life Science Analytics Market

  • In March 2025, Oracle (US) collaborated with NVIDIA Corp (US) to integrate NVIDIA's accelerated computing and AI software with Oracle Cloud Infrastructure (OCI). This collaboration aims to help enterprises develop and deploy agentic AI applications more efficiently.
  • In March 2025, IQVIA (US) launched a site lab navigator to automate and streamline laboratory workflows for clinical trial sponsors and investigator sites.
  • In March 2025, Cognizant (US) launched a unified cloud platform called the "One Medicine Platform," aimed at accelerating the delivery of innovative therapies to patients.
  • In January 2025, IQVIA (US) partnered with NVIDIA Corp (US) to advance AI applications in healthcare and life sciences. This partnership aims to combine IQVIA's extensive data assets and domain expertise with NVIDIA's AI technologies to enhance automation and efficiency across various stages of the therapeutic lifecycle.
  • In January 2025, MaxisIT (US) launched Site Copilot, a conversational AI agent designed to transform clinical trial site operations.
  • In December 2024, Oracle (US) collaborated with Nashville General Hospital (US) to implement Oracle Health CommunityWorks to unify its clinical, financial, and operational systems across the hospital and more than 20 outpatient and clinic settings.
  • In July 2024, Indegene partnered with Microsoft to scale generative AI adoption in life sciences, enhancing innovation and efficiency across the industry.
  • In June 2024, SAS launched its analytics platform, SAS Clinical Acceleration Repository, to streamline clinical trial development, expedite the regulatory submission process, control data from clinical research, and interface with several data sources.
  • In June 2024, IQVIA launched the One Home for Sites platform to streamline clinical trial management by consolidating multiple systems into a single dashboard, reducing the administrative burden on research sites.
  • In March 2024, Cognizant collaborated with NVIDIA to leverage the BioNeMo generative AI platform for accelerated drug discovery, aiming at higher productivity with reduced development expense in life sciences.

Key Market Players

KEY PLAYERS IN THE LIFE SCIENCE ANALYTICS MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Life Science Analytics Market?

Scope of the Report

Report Metric Details
Market size available for years 2023-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Million/Billion (USD)
Segments covered Type, Component, Application, and End User
Geographies covered North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Key Questions Addressed by the Report

Which are the top industry players in the global life science analytics market?
The top market players include Oracle (US), Merative (formerly IBM) (US), SAS Institute (US), Accenture (Ireland), IQVIA (US), Cognizant (US), Wipro (India), Veradigm (US), Optum (US), Microsoft (US), MaxisIT (US), ExlService Holdings (US), Inovalon (US), CitiusTech (US), Saama (US), Axtria (US), Clarivate (UK), ThoughtSphere (US), ThoughtSpot (US), Salesforce (US), Google LLC (US), Amazon Web Services (US), Veeva Systems (US), Elsevier (Netherlands), Komodo Health (US).
Which components have been included in the life science analytics market report?
This report contains the following components:
  • Software
  • Services
Which geographical region is dominating the global life science analytics market?
North America holds a substantial share of the global market, while the Asia Pacific region is expected to register the highest growth rate during the forecast period.
Which end users have been included in the life science analytics market report?
The report contains the following industry segments:
  • Pharmaceutical & Biotechnology Companies
  • Medical Device Companies
  • Research Centers
  • Outsourced Life Science Organizations
What is the total CAGR expected to be recorded for the life science analytics market during 2025–2030?
The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 11.4% from 2025 to 2030.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Life Science Analytics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
37
RESEARCH METHODOLOGY
42
EXECUTIVE SUMMARY
54
PREMIUM INSIGHTS
58
MARKET OVERVIEW
62
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rising pressure to curb healthcare spending
    - Need for improved data standardization
    - Technological advancements in analytical solutions
    - Heterogeneity and complexity of big data in life sciences
    - Growing adoption of analytical solutions in clinical trials
    - Increasing R&D expenditure in pharmaceutical & biotechnology companies
    RESTRAINTS
    - High implementation costs of advanced analytical solutions
    - Data privacy concerns
    OPPORTUNITIES
    - Growing focus on value-based care
    - Use of analytics in precision & personalized medicine
    - Big data analytics for R&D productivity
    - Growing adoption of cloud-based analytics
    CHALLENGES
    - Issues associated with data integration
    - Shortage of skilled personnel
    - Reluctance to adopt life science analytics solutions in emerging countries
  • 5.3 INDUSTRY TRENDS
    GROWING ADOPTION OF ANALYTICS IN COMMERCIAL OPERATIONS
    LEVERAGING DATA & ANALYTICS TO ACCELERATE DRUG DISCOVERY & DEVELOPMENT
    FOCUS ON REAL-TIME DATA ANALYTICS
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Artificial intelligence and machine learning
    - Big data analytics
    - Quantum computing
    COMPLEMENTARY TECHNOLOGIES
    - Bioinformatics tools
    - Internet of Things
    ADJACENT TECHNOLOGIES
    - Blockchain
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.9 CASE STUDY ANALYSIS
    NOVARTIS USES MULTI-CLOUD DATA ANALYTICS PLATFORM TO OPTIMIZE OPERATIONS AND ACCELERATE INNOVATION
    SAS VISUAL ANALYTICS HELPS MAXIMIZE PROFITABILITY THROUGH PRESCRIPTIVE ANALYTICS & DATA VISUALIZATION
    STREAMLINING REGULATORY MONITORING AND IMPACT ASSESSMENTS: GEDEON RICHTER’S PARTNERSHIP WITH CLARIVATE
  • 5.10 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    NORTH AMERICA
    EUROPE
    ASIA PACIFIC
    MIDDLE EAST & AFRICA
    LATIN AMERICA
  • 5.11 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF KEY PLAYERS, BY APPLICATION
    AVERAGE SELLING PRICE, BY REGION
  • 5.12 KEY CONFERENCES AND EVENTS, 2025–2026
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.14 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS
    JURISDICTION ANALYSIS: TOP APPLICANT
    MAJOR PATENTS
  • 5.15 END USER ANALYSIS
    UNMET NEEDS
    END-USER EXPECTATIONS
  • 5.16 LIFE SCIENCE ANALYTICS BUSINESS MODELS
    SUBSCRIPTION-BASED MODEL
    SAAS MODEL
    PAY-PER-USE/USAGE-BASED MODEL
    ENTERPRISE LICENSING
    FREEMIUM MODEL
    ENTERPRISE LICENSING
    CONCURRENT LICENSING
    CONSULTING SERVICES MODEL
    PARTNERSHIP/REVENUE-SHARING MODEL
    - HYBRID MODELS
  • 5.17 INVESTMENT & FUNDING SCENARIO
  • 5.18 IMPACT OF AI/GENERATIVE AI ON LIFE SCIENCE ANALYTICS MARKET
    TOP USE CASES & MARKET POTENTIAL
    - Key use cases
    CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
    - Case study 1: Knowledge mining for a global biopharmaceutical company
    - Healthcare analytics market
    USER READINESS AND IMPACT ASSESSMENT
    - User readiness
    - Impact assessment
IMPACT OF 2025 US TARIFF—OVERVIEW
118
  • 6.1 INTRODUCTION
  • 6.2 KEY TARIFF RATES
  • 6.3 PRICE IMPACT ANALYSIS
  • 6.4 IMPACT ON COUNTRY/REGION
    US
    EUROPE
    ASIA PACIFIC
  • 6.5 IMPACT ON END-USE INDUSTRIES
LIFE SCIENCE ANALYTICS MARKET, BY TYPE
123
  • 7.1 INTRODUCTION
  • 7.2 DESCRIPTIVE ANALYTICS
    ADVANCED VISUAL DATA EXPLORATION AND SUPPORT FOR INNOVATION TO DRIVE DEMAND
  • 7.3 PREDICTIVE ANALYTICS
    SIMULATION DEVELOPMENT FOR PREDICTING FUTURE TRENDS TO PROPEL MARKET GROWTH
  • 7.4 PRESCRIPTIVE ANALYTICS
    REAL-TIME ANALYSIS FOR IMPROVED DECISION-MAKING TO SUPPORT MARKET GROWTH
LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT
129
  • 8.1 INTRODUCTION
  • 8.2 SERVICES
    MANAGED SERVICES
    - Analytical services
    - Consulting services
    PROFESSIONAL SERVICES
    - Training & implementation services
    - Maintenance & support services
    - Other professional services
  • 8.3 SOFTWARE
    ON-PREMISES
    - Provision of multivendor architecture and security benefits to drive market
    CLOUD-BASED
    - Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption
    SAAS-BASED
    - Increasing adoption of digital solutions and advantages of cloud-based models to drive growth
LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION
147
  • 9.1 INTRODUCTION
  • 9.2 RESEARCH & DEVELOPMENT
    CLINICAL TRIALS
    - Laboratory services
    - Patient recruitment services
    - Site identification services
    - Other clinical trial services
    - Life science analytics market for clinical trials, by phase
    - PHASE I
    - PHASE II
    - PHASE III
    PRECLINICAL & DRUG DISCOVERY
    - Ability to assist researchers in process innovation and decision support to drive adoption
  • 9.3 COMMERCIAL ANALYTICS
    SALES & MARKETING SUPPORT
    - Rising analysis of digital marketing effectiveness to drive adoption
    MARKET ACCESS
    - Focus on strategic pricing, reimbursement, and policy changes to support market growth
    RWE & VALUE EVIDENCE
    - Increased data integration, partnerships, and technological to propel use of RWE
    ENGAGEMENT SERVICES
    - Need for better patient engagement, digital advancements, and AI integration to propel market
  • 9.4 REGULATORY COMPLIANCE
    STRINGENT REQUIREMENTS FOR COMPLIANCE ADHERENCE TO DRIVE ADOPTION
  • 9.5 MANUFACTURING & SUPPLY CHAIN OPTIMIZATION
    RISING NEED FOR REDUCING LOGISTICS COSTS TO SUPPORT MARKET GROWTH
  • 9.6 SAFETY
    PHARMACOVIGILANCE
    - Monitoring of drug trials and medication programs to fuel market uptake
    MEDICAL DEVICE SAFETY
    - Stringent safety standards, rigorous risk assessments, and robust quality control to drive demand
    DIAGNOSTIC VIGILANCE
    - Continuous monitoring, integration of diverse data sources, and ongoing education to enhance accuracy and thoroughness
LIFE SCIENCE ANALYTICS MARKET, BY END USER
178
  • 10.1 INTRODUCTION
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    RISING NEED FOR INNOVATIVE THERAPIES TO DRIVE ANALYTICS USAGE IN PRODUCT DEVELOPMENT
  • 10.3 MEDICAL DEVICE COMPANIES
    ADOPTION OF DATA ANALYTICS FOR DEVICE COMMERCIALIZATION TO DRIVE MARKET
  • 10.4 RESEARCH CENTERS
    NEED FOR ANALYZING LARGE VOLUMES OF DATA TO SUPPORT MARKET GROWTH
  • 10.5 OUTSOURCED LIFE SCIENCE ORGANIZATIONS
    RISING R&D OUTSOURCING BY LIFE SCIENCE COMPANIES TO DRIVE MARKET
LIFE SCIENCE ANALYTICS MARKET, BY REGION
184
  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    NORTH AMERICA: MACROECONOMIC OUTLOOK
    US
    - Established economy and increasing R&D expenditure to drive adoption of analytical solutions
    CANADA
    - Rising need for data standardization in life sciences to fuel uptake
  • 11.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Growing R&D investments by pharmaceutical & biotechnology companies to drive market
    FRANCE
    - Growing government support for adoption of AI & big data analytics to drive market
    UK
    - Rising clinical trial activity to drive uptake of life science analytics solutions
    ITALY
    - Growing number of drug approvals to drive uptake of analytics solutions
    SPAIN
    - Surging government investments focusing on personalized medicine to drive growth
    REST OF EUROPE
  • 11.4 ASIA PACIFIC
    ASIA PACIFIC: MACROECONOMIC OUTLOOK
    JAPAN
    - Growing government support for clinical R&D activities to drive adoption
    CHINA
    - Growth in life science industry to support adoption of solutions
    INDIA
    - Rising R&D expenditure and drug development to support market growth
    REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    LATIN AMERICA: MACROECONOMIC OUTLOOK
    BRAZIL
    - Brazil to dominate life science analytics market in Latin America
    MEXICO
    - Growing prominence of startups and rising R&D activity to propel market
    REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
    GCC COUNTRIES
    - Rising investments, advancements, and developing healthcare infrastructure to drive market
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
299
  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET
  • 12.3 REVENUE ANALYSIS
  • 12.4 MARKET SHARE ANALYSIS
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Region footprint
    - Type footprint
    - Application footprint
    - Component footprint
    - End user footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING
  • 12.7 BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • 12.8 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.9 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF LIFE SCIENCE ANALYTICAL VENDORS
  • 12.10 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & ENHANCEMENTS
    DEALS
COMPANY PROFILES
323
  • 13.1 KEY PLAYERS
    ORACLE
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    MERATIVE
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    SAS INSTITUTE INC.
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    ACCENTURE
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    IQVIA INC.
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    COGNIZANT
    - Business overview
    - Products & services offered
    - Recent developments
    WIPRO
    - Business overview
    - Products & services offered
    - Recent developments
    VERADIGM LLC
    - Business overview
    - Products & services offered
    - Recent developments
    - Recent developments
    OPTUM, INC.
    - Business overview
    - Products & services offered
    MICROSOFT
    - Business overview
    - Products & services offered
    - Recent developments
    MAXISIT
    - Business overview
    - Products & services offered
    - Recent developments
    EXLSERVICE HOLDINGS, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    INOVALON
    - Business overview
    - Products & services offered
    - Recent developments
    CITIUSTECH INC.
    - Business overview
    - Products & services offered
    - Recent developments
    SAAMA
    - Business overview
    - Products & services offered
    - Recent developments
    - Recent developments
    AXTRIA
    - Business overview
    - Products & services offered
    - Recent developments
    CLARIVATE
    - Business overview
    - Products & services offered
    - Recent developments
    THOUGHTSPHERE
    - Business overview
    - Products & services offered
    THOUGHTSPOT INC.
    - Business overview
    - Products & services offered
    - Recent developments
    SALESFORCE, INC.
    - Business overview
    - Products & services offered
    - Recent developments
  • 13.2 OTHER PLAYERS
    GOOGLE LLC
    AMAZON WEB SERVICES, INC.
    VEEVA SYSTEMS
    ELSEVIER
    KOMODO HEALTH, INC.
APPENDIX
396
  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 2 LIFE SCIENCE ANALYTICS MARKET: RISK ASSESSMENT
  • TABLE 3 MARKET DYNAMICS: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN AI IN TELEHEALTH & TELEMEDICINE MARKET
  • TABLE 4 PHARMACEUTICAL COMPANIES IMPACTED BY CYBER INCIDENTS, 2024
  • TABLE 5 LIFE SCIENCE ANALYTICS MARKET: ROLE IN ECOSYSTEM
  • TABLE 6 LIFE SCIENCE ANALYTICS MARKET: PORTER’S FIVE FORCES
  • TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
  • TABLE 8 KEY BUYING CRITERIA FOR END USERS
  • TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 AVERAGE SELLING PRICE OF LIFE SCIENCE ANALYTICS SOLUTIONS, BY APPLICATION
  • TABLE 15 AVERAGE SELLING PRICE OF ANALYTICS SOLUTIONS, BY REGION
  • TABLE 16 LIFE SCIENCE ANALYTICS MARKET: LIST OF KEY CONFERENCES AND EVENTS
  • TABLE 17 LIST OF PATENTS/PATENT APPLICATIONS
  • TABLE 18 UNMET NEEDS IN LIFE SCIENCE ANALYTICS MARKET
  • TABLE 19 END-USER EXPECTATIONS IN LIFE SCIENCE ANALYTICS MARKET
  • TABLE 20 MAJOR INVESTMENTS IN AI IN LIFE SCIENCE ANALYTICS MARKET
  • TABLE 21 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 22 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 23 DESCRIPTIVE ANALYTICS: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 24 PREDICTIVE ANALYTICS: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 25 PRESCRIPTIVE ANALYTICS: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 26 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 27 LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 28 LIFE SCIENCE ANALYTICS MARKET FOR SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 29 LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 30 LIFE SCIENCE ANALYTICS MARKET FOR MANAGED SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 31 LIFE SCIENCE ANALYTICS MARKET FOR ANALYTICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 32 LIFE SCIENCE ANALYTICS MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 33 LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 34 LIFE SCIENCE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 35 LIFE SCIENCE ANALYTICS MARKET FOR TRAINING & IMPLEMENTATION SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 36 LIFE SCIENCE ANALYTICS MARKET FOR MAINTENANCE & SUPPORT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 37 LIFE SCIENCE ANALYTICS MARKET FOR OTHER PROFESSIONAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 38 LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 39 LIFE SCIENCE ANALYTICS MARKET FOR SOFTWARE, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 40 LIFE SCIENCE ANALYTICS MARKET FOR ON-PREMISES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 41 LIFE SCIENCE ANALYTICS MARKET FOR CLOUD-BASED, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 42 LIFE SCIENCE ANALYTICS MARKET FOR SAAS-BASED, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 43 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 44 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE R&D SOLUTIONS
  • TABLE 45 LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 46 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 47 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE CLINICAL TRIAL SOLUTIONS
  • TABLE 48 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 49 LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 50 LIFE SCIENCE ANALYTICS MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 51 LIFE SCIENCE ANALYTICS MARKET FOR PATIENT RECRUITMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 52 LIFE SCIENCE ANALYTICS MARKET FOR SITE IDENTIFICATION SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 53 LIFE SCIENCE ANALYTICS MARKET FOR OTHER CLINICAL TRIAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 54 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 55 LIFE SCIENCE ANALYTICS MARKET FOR PHASE I CLINICAL TRIALS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 56 LIFE SCIENCE ANALYTICS MARKET FOR PHASE II CLINICAL TRIALS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 57 LIFE SCIENCE ANALYTICS MARKET FOR PHASE III CLINICAL TRIALS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 58 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PRECLINICAL & DRUG DISCOVERY SOLUTIONS
  • TABLE 59 LIFE SCIENCE ANALYTICS MARKET FOR PRECLINICAL & DRUG DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 60 LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 61 LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 62 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE SALES & MARKETING SOLUTIONS
  • TABLE 63 LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING SUPPORT, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 64 LIFE SCIENCE ANALYTICS MARKET FOR MARKET ACCESS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 65 LIFE SCIENCE ANALYTICS MARKET FOR RWE & VALUE EVIDENCE, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 66 LIFE SCIENCE ANALYTICS MARKET FOR ENGAGEMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 67 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE REGULATORY COMPLIANCE SOLUTIONS
  • TABLE 68 LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 69 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE MANUFACTURING & SUPPLY CHAIN OPTIMIZATION SOLUTIONS
  • TABLE 70 LIFE SCIENCE ANALYTICS MARKET FOR MANUFACTURING & SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 71 LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 72 LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 73 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PHARMACOVIGILANCE SOLUTIONS
  • TABLE 74 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 75 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE SAFETY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 76 LIFE SCIENCE ANALYTICS MARKET FOR DIAGNOSTIC VIGILANCE, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 77 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 78 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 79 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 80 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 81 LIFE SCIENCE ANALYTICS MARKET FOR OUTSOURCED LIFE SCIENCE ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 82 LIFE SCIENCE ANALYTICS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 83 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 84 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 85 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 86 NORTH AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 87 NORTH AMERICA: MANAGED SERVICES MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 88 NORTH AMERICA: PROFESSIONAL SERVICES MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 89 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 90 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 91 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 92 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 93 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 94 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 95 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 96 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 97 US: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 98 US: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 99 US: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 100 US: MANAGED SERVICES MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 101 US: PROFESSIONAL SERVICES MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 102 US: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 103 US: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 104 US: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 105 US: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 106 US: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 107 US: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 108 US: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 109 US: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 110 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 111 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 112 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY SERVICES TYPE, 2023–2030 (USD MILLION)
  • TABLE 113 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 114 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 115 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 116 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 117 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 118 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 119 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 120 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 121 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 122 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 123 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 124 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 125 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 126 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 127 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 128 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 129 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 130 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 131 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 132 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 133 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 134 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 135 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 136 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 137 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 138 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 139 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 140 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 141 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 142 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 143 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 144 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 145 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 146 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 147 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 148 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 149 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 150 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 151 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 152 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 153 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 154 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 155 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 156 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 157 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 158 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 159 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 160 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 161 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 162 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 163 UK: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 164 UK: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 165 UK: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 166 UK: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 167 UK: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 168 UK: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 169 UK: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 170 UK: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 171 UK: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 172 UK: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 173 UK: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 174 UK: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 175 UK: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 176 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 177 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 178 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 179 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 180 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 181 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 182 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 183 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 184 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 185 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 186 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 187 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 188 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 189 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 190 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 191 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 192 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 193 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 194 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 195 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 196 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 197 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 198 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 199 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 200 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 201 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 202 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 203 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 204 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 205 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 206 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 207 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 208 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 209 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 210 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 211 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 212 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 213 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 214 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 215 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 216 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 218 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 220 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 221 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 222 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 223 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 224 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 225 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 226 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 227 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 228 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 229 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 230 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 231 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 232 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 233 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 234 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 235 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 236 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 237 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 238 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 239 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 240 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 241 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 242 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 243 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 244 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 245 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 246 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 247 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 248 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 249 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 250 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 251 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 252 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 253 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 254 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 255 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 256 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 257 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 258 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 259 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 260 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 261 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 262 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 263 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 264 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 265 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 266 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 267 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 268 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 269 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 270 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 271 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 272 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 273 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 274 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 275 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 276 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 277 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 278 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 279 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 280 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 281 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 282 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 283 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 284 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 285 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 286 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 287 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 288 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 289 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 290 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 291 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 292 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 293 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 294 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 295 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 296 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 297 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 298 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 299 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 300 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 301 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 302 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 303 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 304 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 305 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 306 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 307 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 308 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 309 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 310 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 311 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 312 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 313 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 314 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 315 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 316 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 317 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 318 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 319 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 320 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 321 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 322 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 323 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 324 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 325 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 326 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)SOFTWARE
  • TABLE 327 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 328 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 329 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 330 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 331 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 332 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 333 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 334 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 335 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 336 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 337 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 338 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 339 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 340 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 341 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 342 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 343 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 344 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 345 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 346 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 347 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 348 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 349 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 350 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 351 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 352 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 353 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 354 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 355 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 356 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 357 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 358 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 359 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 360 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 361 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 362 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
  • TABLE 363 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 364 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 365 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION)
  • TABLE 366 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)
  • TABLE 367 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 368 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 369 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION)
  • TABLE 370 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION)
  • TABLE 371 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 372 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION)
  • TABLE 373 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 374 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET
  • TABLE 375 LIFE SCIENCE ANALYTICS MARKET: DEGREE OF COMPETITION
  • TABLE 376 LIFE SCIENCE ANALYTICS MARKET: REGION FOOTPRINT (25 COMPANIES)
  • TABLE 377 LIFE SCIENCE ANALYTICS MARKET: TYPE FOOTPRINT (25 COMPANIES)
  • TABLE 378 LIFE SCIENCE ANALYTICS MARKET: APPLICATION FOOTPRINT (25 COMPANIES)
  • TABLE 379 LIFE SCIENCE ANALYTICS MARKET: COMPONENT FOOTPRINT (25 COMPANIES)
  • TABLE 380 LIFE SCIENCE ANALYTICS MARKET: END USER FOOTPRINT (25 COMPANIES)
  • TABLE 381 LIFE SCIENCE ANALYTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 382 LIFE SCIENCE ANALYTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES)
  • TABLE 383 LIFE SCIENCE ANALYTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 384 LIFE SCIENCE ANALYTICS MARKET: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 385 ORACLE: COMPANY OVERVIEW
  • TABLE 386 ORACLE: PRODUCTS & SERVICES OFFERED
  • TABLE 387 ORACLE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 388 ORACLE: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 389 MERATIVE: COMPANY OVERVIEW
  • TABLE 390 MERATIVE: PRODUCTS & SERVICES OFFERED
  • TABLE 391 MERATIVE: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 392 MERATIVE: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
  • TABLE 393 SAS INSTITUTE: COMPANY OVERVIEW
  • TABLE 394 SAS INSTITUTE: PRODUCTS & SERVICES OFFERED
  • TABLE 395 SAS INSTITUTE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 396 SAS INSTITUTE: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 397 ACCENTURE: COMPANY OVERVIEW
  • TABLE 398 ACCENTURE: PRODUCTS OFFERED
  • TABLE 399 ACCENTURE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 400 ACCENTURE: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 401 ACCENTURE: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
  • TABLE 402 IQVIA: COMPANY OVERVIEW
  • TABLE 403 IQVIA: PRODUCTS & SERVICES OFFERED
  • TABLE 404 IQVIA: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 405 IQVIA: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 406 IQVIA: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
  • TABLE 407 COGNIZANT: COMPANY OVERVIEW
  • TABLE 408 COGNIZANT: PRODUCTS & SERVICES OFFERED
  • TABLE 409 COGNIZANT: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 410 COGNIZANT: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 411 WIPRO: COMPANY OVERVIEW
  • TABLE 412 WIPRO: PRODUCTS & SERVICES OFFERED
  • TABLE 413 WIPRO: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 414 VERADIGM: COMPANY OVERVIEW
  • TABLE 415 VERADIGM: PRODUCTS & SERVICES OFFERED
  • TABLE 416 VERADIGM: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 417 VERADIGM: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 418 OPTUM: COMPANY OVERVIEW
  • TABLE 419 OPTUM: PRODUCTS & SERVICES OFFERED
  • TABLE 420 MICROSOFT: COMPANY OVERVIEW
  • TABLE 421 MICROSOFT: PRODUCTS & SERVICES OFFERED
  • TABLE 422 MICROSOFT: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 423 MICROSOFT: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 424 MAXISIT: COMPANY OVERVIEW
  • TABLE 425 MAXISIT: PRODUCTS & SERVICES OFFERED
  • TABLE 426 MAXISIT: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 427 EXLSERVICE HOLDINGS: COMPANY OVERVIEW
  • TABLE 428 EXLSERVICE HOLDINGS: PRODUCTS & SERVICES OFFERED
  • TABLE 429 EXLSERVICE HOLDINGS: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 430 EXLSERVICE HOLDINGS: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 431 INOVALON: COMPANY OVERVIEW
  • TABLE 432 INOVALON: PRODUCTS & SERVICES OFFERED
  • TABLE 433 INOVALON: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 434 INOVALON: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 435 CITIUSTECH: COMPANY OVERVIEW
  • TABLE 436 CITIUSTECH: PRODUCTS & SERVICES OFFERED
  • TABLE 437 CITIUSTECH: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 438 CITIUSTECH: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 439 CITIUSTECH: EXPANSIONS, JANUARY 2022–MARCH 2025
  • TABLE 440 SAAMA: COMPANY OVERVIEW
  • TABLE 441 SAAMA: PRODUCTS & SERVICES OFFERED
  • TABLE 442 SAAMA: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 443 SAAMA: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 444 SAAMA: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
  • TABLE 445 AXTRIA: COMPANY OVERVIEW
  • TABLE 446 AXTRIA: PRODUCTS & SERVICES OFFERED
  • TABLE 447 AXTRIA: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 448 AXTRIA: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 449 AXTRIA: EXPANSIONS, JANUARY 2022–MARCH 2025
  • TABLE 450 CLARIVATE: COMPANY OVERVIEW
  • TABLE 451 CLARIVATE: PRODUCTS & SERVICES OFFERED
  • TABLE 452 CLARIVATE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 453 CLARIVATE: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 454 THOUGHTSPHERE: COMPANY OVERVIEW
  • TABLE 455 THOUGHTSPHERE: PRODUCTS & SERVICES OFFERED
  • TABLE 456 THOUGHTSPOT: COMPANY OVERVIEW
  • TABLE 457 THOUGHTSPOT: PRODUCTS & SERVICES OFFERED
  • TABLE 458 THOUGHTSPOT: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 459 THOUGHTSPOT: DEALS, JANUARY 2022–MARCH 2025
  • TABLE 460 SALESFORCE: COMPANY OVERVIEW
  • TABLE 461 SALESFORCE: PRODUCTS & SERVICES OFFERED
  • TABLE 462 SALESFORCE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025
  • TABLE 463 SALESFORCE: DEALS, JANUARY 2022–MARCH 2025
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 5 LIFE SCIENCE ANALYTICS MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION
  • FIGURE 6 BOTTOM-UP APPROACH: END-USER SPENDING ON LIFE SCIENCE ANALYTICS
  • FIGURE 7 LIFE SCIENCE ANALYTICS MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030)
  • FIGURE 8 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
  • FIGURE 9 TOP-DOWN APPROACH
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 LIFE SCIENCE ANALYTICS MARKET: REGIONAL SNAPSHOT
  • FIGURE 16 RISING TECHNOLOGICAL ADVANCEMENTS AND GROWING ADOPTION OF ANALYTICS SOLUTIONS FOR CLINICAL TRIALS TO DRIVE MARKET
  • FIGURE 17 NORTH AMERICA TO DOMINATE LIFE SCIENCE ANALYTICS MARKET THROUGHOUT FORECAST PERIOD
  • FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND US HELD LARGEST MARKET SHARE IN NORTH AMERICA IN 2024
  • FIGURE 19 CHINA TO REGISTER HIGHEST CAGR IN GLOBAL MARKET DURING FORECAST PERIOD
  • FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 21 LIFE SCIENCE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 HEALTH EXPENDITURE AS SHARE OF GDP, 2022 (OR NEAREST YEAR)
  • FIGURE 23 LIFE SCIENCE ANALYTICS MARKET ECOSYSTEM
  • FIGURE 24 LIFE SCIENCE ANALYTICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 LIFE SCIENCE ANALYTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • FIGURE 27 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 28 REVENUE SHIFT IN LIFE SCIENCE ANALYTICS MARKET
  • FIGURE 29 JURISDICTION ANALYSIS: TOP APPLICANTS FOR LIFE SCIENCE ANALYTICS PATENTS, JANUARY 2011–MARCH 2025
  • FIGURE 30 MAJOR PATENTS FOR LIFE SCIENCE ANALYTICS, JANUARY 2011– MARCH 2025
  • FIGURE 31 FUNDING OF PLAYERS IN LIFE SCIENCE ANALYTICS MARKET
  • FIGURE 32 MARKET POTENTIAL OF AI/GENERATIVE AI, BY INDUSTRY
  • FIGURE 33 IMPACT OF GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
  • FIGURE 34 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
  • FIGURE 35 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
  • FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET, 2020–2024
  • FIGURE 37 LIFE SCIENCE ANALYTICS MARKET: MARKET SHARE ANALYSIS (2024)
  • FIGURE 38 LIFE SCIENCE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 39 LIFE SCIENCE ANALYTICS MARKET: COMPANY FOOTPRINT (25 COMPANIES)
  • FIGURE 40 LIFE SCIENCE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF LIFE SCIENCE ANALYTICS VENDORS
  • FIGURE 43 ORACLE: COMPANY SNAPSHOT
  • FIGURE 44 ACCENTURE: COMPANY SNAPSHOT
  • FIGURE 45 IQVIA: COMPANY SNAPSHOT
  • FIGURE 46 COGNIZANT: COMPANY SNAPSHOT
  • FIGURE 47 WIPRO: COMPANY SNAPSHOT
  • FIGURE 48 VERADIGM: COMPANY SNAPSHOT
  • FIGURE 49 UNITED HEALTH GROUP: COMPANY SNAPSHOT
  • FIGURE 50 MICROSOFT: COMPANY SNAPSHOT
  • FIGURE 51 EXLSERVICE HOLDINGS: COMPANY SNAPSHOT
  • FIGURE 52 CLARIVATE: COMPANY SNAPSHOT
  • FIGURE 53 SALESFORCE: COMPANY SNAPSHOT

The study involved several key activities to estimate the current size of the life science analytics market. Extensive secondary research was conducted to gather information on this market. The next step was to validate the findings, assumptions, and size estimates by consulting industry experts throughout the value chain through primary research. We employed various methods, including top-down and bottom-up approaches, to estimate the overall market size. Following this, we utilized market segmentation and data triangulation techniques to determine the size of specific segments and subsegments within the life science analytics market.

Secondary Research

This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Business, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for companies providing life science analytics solutions is assessed using secondary data from both paid and free sources. This involves analyzing the product portfolios of major players in the industry and evaluating these companies based on their performance and quality. Various resources were utilized in the secondary research process to gather information for this study. The sources include annual reports, press releases, investor presentations, white papers, academic journals, certified publications, articles by recognized authors, directories, and databases.

The secondary research process involved referring to various secondary sources to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of life science analytics vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

Primary research was conducted to identify segmentation types; industry trends; key players; and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies adopted by key players.

After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of life science analytics solutions offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

Breakdown of Primary Respondents:

Life Science Analytics Market

Note 1: Others include sales, marketing, and product managers.

Note 2: Tiers are defined based on a company’s total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by type, component, application, end user, and region).

Life Science Analytics Market

Data Triangulation

After arriving at the overall market size, using the market size estimation processes, the market was split into several segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the life science analytics market.

Market Definition

Life science analytics is the efficient use of data and related business insights developed through statistical, quantitative, predictive, comparative, cognitive, and other emerging applied analytical models. Life science analytics tools help reveal and understand historical data patterns, predict future outcomes, and provide actionable insights to drive fact-based decision-making for improved performance of life science organizations.

Stakeholders

  • Pharmaceutical and biotechnology companies
  • Medical device companies
  • Contract research organizations (CROs)
  • Life science analytics vendors
  • Platform providers
  • Technology providers
  • System integrators
  • Healthcare IT service providers
  • Forums, alliances, and associations
  • Distributors
  • Government organizations
  • Academic research institutes
  • Institutional investors and investment banks
  • Investors/Shareholders
  • Venture capitalists
  • Research and consulting firms

Report Objectives

  • To define, describe, and forecast the global life science analytics market based on type, component, application, end user, and region
  • To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall life science analytics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the life science analytics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
  • To track and analyze competitive developments such as product & service launches; expansions; partnerships, agreements, and collaborations; and acquisitions in the life science analytics market
  • To benchmark players within the life science analytics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

 

Previous Versions of this Report

Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Sales & Marketing, Regulatory Compliance, R&D, Pharmacovigilance), Component (Software, Service), Delivery (On Premise, On Demand), End User & Region - Global Forecast to 2027

Report Code HIT 4869
Published in Oct, 2024, By MarketsandMarkets™

Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, Clinical trial, R&D, Pharmacovigilance, SCM), Component (Software, Service), Delivery, End User, Region - Global Forecasts to 2025

Report Code HIT 4869
Published in Feb, 2023, By MarketsandMarkets™

Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, Clinical trial, R&D, Pharmacovigilance, SCM), Component (Software, Service), Delivery, End User, Region - Global Forecast to 2025

Report Code HIT 4869
Published in Sep, 2020, By MarketsandMarkets™

Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, R&D, Pharmacovigilance, SCM), Component (Software, Service), Delivery (On Premise, Cloud), End User - Global Forecast to 2024

Report Code HIT 4869
Published in Jul, 2019, By MarketsandMarkets™

Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, R&D, Pharmacovigilance, SCM), Component (Software, Service), Delivery (On Premise, Cloud), End User - Global Forecast to 2024

Report Code HIT 4869
Published in Jan, 2017, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Life Science Analytics Market

DMCA.com Protection Status